PHATHOM PHARMACEUTICALS INC PHAT
COM · Common Stock · CUSIP 71722W107 · ISIN US71722W1071
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersFlorham Park, NJ
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 31.4m as of 2021-08-05, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $33.85. Options: 2 managers hold calls ($339.0k notional), 1 hold puts ($0).
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 41 |
| Q1 2020 | 48 |
| Q2 2020 | 62 |
| Q3 2020 | 59 |
| Q4 2020 | 77 |
| Q1 2021 | 85 |
| Q2 2021 | 80 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 25 | 17 |
| Q2 2020 | 41 | 13 |
| Q3 2020 | 13 | 29 |
| Q4 2020 | 45 | 20 |
| Q1 2021 | 41 | 36 |
| Q2 2021 | 45 | 31 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2020 | $0 | $0 | — |
| Q4 2020 | $718.0k | $979.0k | 1.36 |
| Q1 2021 | $0 | $3.0k | — |
| Q2 2021 | $339.0k | $0 | 0.00 |
Biggest buyers
| BlackRock Inc. | Added | +344.5k |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. | New | +171.4k |
| STATE STREET CORP | Added | +123.1k |
| JACOBS LEVY EQUITY MANAGEMENT, INC | New | +115.3k |
| WCM INVESTMENT MANAGEMENT, LLC | New | +104.0k |
| VANGUARD GROUP INC | Added | +79.7k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +71.9k |
| CITADEL ADVISORS LLC | Added | +71.8k |
| NORTHERN TRUST CORP | Added | +63.0k |
| Greenspring Associates, LLC | Added | +54.3k |
Biggest sellers
| GILDER GAGNON HOWE & CO LLC | Reduced | -271.9k |
| CAAS CAPITAL MANAGEMENT LP | Sold out | -211.0k |
| JPMORGAN CHASE & CO | Reduced | -182.0k |
| MARSHALL WACE, LLP | Reduced | -84.2k |
| Woodline Partners LP | Sold out | -41.7k |
| Parkman Healthcare Partners LLC | Sold out | -30.2k |
| AVIVA PLC | Sold out | -29.5k |
| California Public Employees Retirement System | Sold out | -29.4k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -26.5k |
| CANADA PENSION PLAN INVESTMENT BOARD | Sold out | -20.0k |
Biggest calls
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | $339.0k10.0k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Frazier Life Sciences Public Fund, L.P.
13D · may seek influence
no change · filed 2025-11-04
Stated purposeItem 4 is hereby amended to remove references to "FLSPOF" and the "FLSPOF Shares" from the first paragraph. Full filing |
8.6% |
| BlackRock, Inc. 13G · institution +0.9 pts · filed 2026-07-29 | 5.5% |
Fell to 5% or below in the last year: MILLENNIUM MANAGEMENT LLC (4.2%, 2026-07-20)
Insider purchases and sales in Q2 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2019 | 0 | — | 0 | — | — |
| Q4 2019 | 0 | — | 0 | — | — |
| Q1 2020 | 0 | — | 1 | $487.3k | — |
| Q2 2020 | 0 | — | 0 | — | — |
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 2 | $5.9m | — |
| Q1 2021 | 0 | — | 3 | $9.0m | — |
| Q2 2021 | 0 | — | 2 | $5.2m | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2021-06-29 | Socks David A Director · David A. Socks 2013 Revocable Trust | Sold | $474.6k14.0k shares |
| 2021-06-28 | Socks David A Director · David A. Socks 2013 Revocable Trust | Sold | $887.3k26.0k shares |
| 2021-06-28 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $13.0k370 shares |
| 2021-06-25 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $856.4k24.1k shares |
| 2021-06-24 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $381.2k10.8k shares |
| 2021-06-23 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $7.0k200 shares |
| 2021-06-22 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $3.5k100 shares |
| 2021-06-21 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $328.2k9.3k shares |
| 2021-06-18 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $189.6k5.4k shares |
| 2021-06-17 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $115.9k3.3k shares |
| 2021-06-14 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $99.1k2.8k shares |
| 2021-06-10 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $73.9k2.1k shares |
| 2021-06-09 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $42.0k1.2k shares |
| 2021-06-08 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $3.5k100 shares |
| 2021-06-07 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $79.4k2.3k shares |
| 2021-06-02 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $151.3k4.3k shares |
| 2021-06-01 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $401.1k11.2k shares |
| 2021-05-28 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $322.3k8.9k shares |
| 2021-05-27 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $314.0k8.5k shares |
| 2021-05-26 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $452.7k12.4k shares |
| 2021-05-25 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $396.1k10.9k shares |
| 2021-05-24 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $377.8k10.6k shares |
| 2021-05-21 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $416.3k11.6k shares |
| 2021-05-20 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $249.1k7.1k shares |
| 2021-05-20 | Socks David A Director · David A. Socks 2013 Revocable Trust | Sold | $120.7k3.5k shares |
| 2021-05-19 | Socks David A Director · David A. Socks 2013 Revocable Trust | Sold | $1.2m36.5k shares |
| 2021-05-14 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $3.5k100 shares |
| 2021-05-13 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $3.5k100 shares |
| 2021-05-12 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $417.4k11.8k shares |
| 2021-05-07 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sold | $35.4k1.0k shares |
The latest 30 of 40 trades.
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| FRAZIER MANAGEMENT LLC 18.19% of their portfolio | 5.8m $197.3m | Unchanged |
| RA CAPITAL MANAGEMENT, L.P. 1.69% of their portfolio | 3.1m $105.4m | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd 12.54% of their portfolio | 2.1m $70.0m | Unchanged |
| Invesco Ltd. 0.02% of their portfolio | 2.0m $68.4m | Reduced -7.5k |
| JANUS HENDERSON GROUP PLC 0.03% of their portfolio | 2.0m $66.1m | Reduced -2.8k |
| VANGUARD GROUP INC 0.00% of their portfolio | 1.6m $52.8m | Added +79.7k |
| Ensign Peak Advisors, Inc 0.08% of their portfolio | 1.2m $41.3m | Reduced -19.5k |
| Abingworth LLP 12.59% of their portfolio | 1.2m $40.7m | Unchanged |
| BlackRock Inc. 0.00% of their portfolio | 1.2m $39.3m | Added +344.5k |
| EVENTIDE ASSET MANAGEMENT, LLC 0.27% of their portfolio | 600.0k $20.3m | Unchanged |
| GILDER GAGNON HOWE & CO LLC 0.09% of their portfolio | 546.5k $18.5m | Reduced -271.9k |
| Greenspring Associates, LLC 0.95% of their portfolio | 415.3k $14.1m | Added +54.3k |
| STATE STREET CORP 0.00% of their portfolio | 340.3k $11.5m | Added +123.1k |
| NORGES BANK 0.00% of their portfolio | 329.3k $11.1m | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 281.4k $9.5m | Added +71.9k |
| GW&K Investment Management, LLC 0.07% of their portfolio | 229.4k $7.8m | Added +29.9k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 194.9k $6.6m | Added +63.0k |
| Rhenman & Partners Asset Management AB 0.43% of their portfolio | 186.2k $6.3m | Added +11.2k |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. 0.07% of their portfolio | 171.4k $5.8m | New |
| JACOBS LEVY EQUITY MANAGEMENT, INC 0.03% of their portfolio | 115.3k $3.9m | New |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio | 107.1k $3.6m | Added +19.9k |
| WCM INVESTMENT MANAGEMENT, LLC 0.01% of their portfolio | 104.0k $3.5m | New |
| Ikarian Capital, LLC 0.60% of their portfolio | 100.0k $3.4m | Unchanged |
| Nuveen Asset Management, LLC 0.00% of their portfolio | 94.1k $3.2m | Added +28.1k |
| Penn Mutual Asset Management 3.68% of their portfolio | 86.9k $2.9m | Unchanged |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.01% of their portfolio | 81.6k $2.8m | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 80.4k $2.7m | Added +71.8k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 63.5k $2.2m | Reduced -1.5k |
| Bank of New York Mellon Corp 0.00% of their portfolio | 50.8k $1.7m | Added +9.6k |
| PURA VIDA INVESTMENTS, LLC 0.11% of their portfolio | 45.2k $1.5m | Reduced -18.6k |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 40.0k $1.4m | Reduced -14.7k |
| SEI INVESTMENTS CO 0.00% of their portfolio | 39.4k $1.3m | New |
| Marshall Wace North America L.P. 0.00% of their portfolio | 34.4k $1.2m | Reduced -3.1k |
| Summit Rock Advisors, LP 0.46% of their portfolio | 34.1k $1.2m | Unchanged |
| Swiss National Bank 0.00% of their portfolio | 31.0k $1.0m | Added +14.4k |
| MARSHALL WACE, LLP 0.01% of their portfolio | 29.7k $1.0m | Reduced -84.2k |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 0.00% of their portfolio | 27.9k $946.0k | Added +10.5k |
| MORGAN STANLEY 0.00% of their portfolio | 26.5k $896.0k | Added +26.4k |
| TWO SIGMA ADVISERS, LP 0.00% of their portfolio | 25.5k $863.0k | Reduced -5.9k |
| CHARTWELL INVESTMENT PARTNERS, LLC 0.02% of their portfolio | 22.6k $765.0k | New |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 17.5k $592.0k | Added +7.8k |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 16.4k $556.0k | Added +5.0k |
| Cambridge Investment Research Advisors, Inc. 0.00% of their portfolio | 16.3k $552.0k | Unchanged |
| STATE OF WISCONSIN INVESTMENT BOARD 0.00% of their portfolio | 14.9k $504.0k | Unchanged |
| PDT Partners, LLC 0.03% of their portfolio | 14.9k $504.0k | New |
| BOOTHBAY FUND MANAGEMENT, LLC 0.02% of their portfolio | 14.9k $504.0k | Added +2.3k |
| Engineers Gate Manager LP 0.03% of their portfolio | 14.3k $484.0k | Added +5.1k |
| Occidental Asset Management, LLC 0.12% of their portfolio | 12.9k $436.0k | Unchanged |
| Russell Investments Group, Ltd. 0.00% of their portfolio | 12.7k $428.0k | New |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 12.6k $425.0k | Added +5.1k |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 12.3k $418.0k | Reduced -182.0k |
| ALLIANCEBERNSTEIN L.P. 0.00% of their portfolio | 12.3k $416.0k | Added +1.8k |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.00% of their portfolio | 11.9k $402.0k | Added +4.8k |
| AMERICAN INTERNATIONAL GROUP, INC. 0.00% of their portfolio | 11.3k $384.0k | Added +4.6k |
| VOYA INVESTMENT MANAGEMENT LLC 0.00% of their portfolio | 8.0k $270.0k | New |
| MetLife Investment Management, LLC 0.00% of their portfolio | 7.8k $262.7k | Added +2.7k |
| CREDIT SUISSE AG/ 0.00% of their portfolio | 6.6k $224.0k | Added +1.2k |
| VIRTUS ADVISERS, LLC 0.09% of their portfolio | 6.5k $219.0k | Reduced -277 |
| Metropolitan Life Insurance Co/NY 0.00% of their portfolio | 5.9k $201.1k | Added +2.4k |
| Amundi 0.00% of their portfolio | 4.5k $153.0k | First filing |
| STRS OHIO 0.00% of their portfolio | 4.1k $138.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 3.8k $130.0k | Added +2.5k |
| CITIGROUP INC 0.00% of their portfolio | 2.8k $96.0k | Added +993 |
| EXANE DERIVATIVES 0.02% of their portfolio | 2.8k $96.6k | Added +871 |
| Legal & General Group Plc 0.00% of their portfolio | 2.4k $82.0k | Added +888 |
| Ameritas Investment Partners, Inc. 0.00% of their portfolio | 1.6k $54.0k | Added +663 |
| Leonteq Securities AG 0.00% of their portfolio | 1.5k $50.8k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 1.4k $47.0k | Added +725 |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 1.2k $41.0k | Unchanged |
| CANADA LIFE ASSURANCE Co 0.00% of their portfolio | 850 $29.0k | Added +707 |
| Cutler Group LLC / CA 0.00% of their portfolio | 700 $23.0k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 699 $24.0k | Reduced -2.2k |
| Tradition Wealth Management, LLC 0.00% of their portfolio | 340 $12.0k | Added +15 |
| Evolution Wealth Advisors, LLC 0.00% of their portfolio | 288 $10.0k | Unchanged |
| SIMPLEX TRADING, LLC 0.00% of their portfolio | 132 $4.0k | Reduced -100 |
| BESSEMER GROUP INC 0.00% of their portfolio | 101 $3.0k | Unchanged |
| NFSG Corp 0.00% of their portfolio | 35 $1.0k | Unchanged |
| US BANCORP \DE\ 0.00% of their portfolio | 17 $1.0k | New |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC 0.00% of their portfolio | 14 $0 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |